Psoriasis, With or Without Psoriatic Arthritis, Associated With Fatigue
By Elana Gotkine HealthDay Reporter
MONDAY, July 1, 2024 -- Psoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American Academy of Dermatology.
Lea Nymand, from Bispebjerg Hospital and the University of Copenhagen in Denmark, and colleagues explored the characteristics of fatigue and its potential drivers among patients with psoriasis with or without PsA. A total of 2,741 adults with psoriasis (of whom 593 also had PsA) and 3,788 controls without psoriasis completed the Multidimensional Fatigue Inventory-20 questionnaire.
The researchers found that compared with the general population, the impact on total fatigue was greatest for PsA, followed by psoriasis (β = 5.22 and 2.10, respectively). Increasing joint pain intensity was associated with overall fatigue among patients with psoriasis with or without PsA (β = 2.23 for each 1-point increase in joint pain numerical rating scale score).
"Main drivers of fatigue were joint pain and itch, whereas psoriasis severity had little impact on fatigue," the authors write. "These findings highlight the importance of a symptom-based approach when treating psoriasis, rather than focusing on objective severity measures alone."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
RA Patients With Mono-, Oligo-Arthritis, High PGA Remain Most Fatigued
FRIDAY, June 28, 2024 -- Rheumatoid arthritis (RA) patients with mono- or oligo-arthritis and high Patient Global Assessment (PGA) at diagnosis remain the most fatigued, according...
Fatigue With Rheumatoid Arthritis Tied to Disease Activity, Education Level
WEDNESDAY, June 26, 2024 -- The Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) and Brief Fatigue Inventory (BFI-C) scores show consistency in...
FDA Expands Pediatric Indication for Rinvoq
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has expanded indications for Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.